Steven Lane

Steven Lane possesses extensive experience in finance within the biopharmaceutical and biotechnology sectors. Currently serving as Finance Director at CN Bio since January 2025, prior roles include Group Director of Finance and Financial Controller at Arecor Therapeutics plc, where responsibilities included internal financial reporting and budget management. Steven's career also encompasses positions such as Business Controller at Sartorius Stedim Biotech and Financial Controller at The Automation Partnership. Early in the career, Steven held roles as Finance Manager at LGC Genomics and Audit Executive at Grant Thornton LLP, complemented by a strong foundation in scientific research as a Senior Research Scientist at MedImmune. Steven's academic credentials include a Ph.D. in Biotechnology from the University of Dundee and a BSc. in Applied Biochemistry from Liverpool John Moores University.